Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Novel platelet-agglutinating protein from a thrombotic thrombocytopenic purpura plasma.
F A Siddiqui, E C Lian
F A Siddiqui, E C Lian
Published October 1, 1985
Citation Information: J Clin Invest. 1985;76(4):1330-1337. https://doi.org/10.1172/JCI112107.
View: Text | PDF
Research Article

Novel platelet-agglutinating protein from a thrombotic thrombocytopenic purpura plasma.

  • Text
  • PDF
Abstract

A novel platelet-agglutinating protein (PAP) was purified approximately 2,000-fold from the plasma of a patient with thrombotic thrombocytopenic purpura (TTP) by ammonium sulfate fractionation, DEAE-Sephacel and concanavalin A-Sepharose chromatographies. On sodium dodecyl sulfate-polyacrylamide gel electrophoresis, with and without reduction, this preparation revealed a major protein band with a molecular weight of 37,000, and a minor band with a molecular weight of 32,000-34,000. After elution from the gel, only the 37,000-mol wt protein corresponding to the major band induced the platelet agglutination. When four normal plasmas and the recovery plasma from the same TTP patient were subjected to the similar purification steps, the 37,000-mol wt major band was absent. The 125I-PAP bound to the platelets in a concentration-dependent manner. The platelet agglutination induced by PAP was not inhibited by hirudin, heparin in the presence of antithrombin III, phenylmethylsulfonyl fluoride, apyrase, aspirin, or prostaglandin I2. However, it was inhibited by IgG from normal adults and from the same TTP patient after recovery. The anti-37,000-mol wt PAP antiserum prepared in the rabbit formed a single precipitin line against the highly purified PAP. Using this antiserum in the Western immunoblotting, the 37,000-mol wt protein band was found in the three TTP plasmas, of which the platelet-agglutinating activity was inhibited by the anti-37,000-mol wt PAP IgG. The 37,000-mol wt immunoprecipitin band was absent in the plasmas obtained from another two TTP patients, two normal subjects, two patients with idiopathic thrombocytopenic purpura, and two patients with disseminated intravascular coagulation. These results suggest that the 37,000-mol wt PAP is present only in certain cases of TTP, and is likely to be responsible for the formation of platelet thrombi in the microcirculation.

Authors

F A Siddiqui, E C Lian

×

Total citations by year

Year: 2015 2010 2007 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1994 1993 1992 1991 1990 1989 1988 1987 1986 Total
Citations: 1 1 1 2 1 2 3 3 1 3 3 3 3 3 3 7 3 5 4 4 4 1 61
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (61)

Title and authors Publication Year
ADAMTS13
GM Rodgers
2015
Thrombotic microangiopathy in haematopoietic cell transplantation: an update
E Stavrou, HM Lazarus
Mediterranean journal of hematology and infectious diseases 2010
Thrombotic Thrombocytopenic Purpura
JL Moake
Consultative Hemostasis and Thrombosis 2007
Effect of plasma exchange on cytokines measured by multianalyte bead array in thrombotic thrombocytopenic purpura
S Shariatmadar, M Nassiri, V Vincek
American Journal of Hematology 2005
Thrombotic thrombocytopenic purpura
B Lammle, JA Hovinga, L Alberio
Journal of Thrombosis and Haemostasis 2005
Thrombotic Thrombocytopenic Purpura: Yesterday, Today, Tomorrow
LJ McCarthy, JS Dlott, A Orazi, D Waxman, CC Miraglia, CF Danielson
Therapeutic Apheresis and Dialysis 2004
Deficient activity of von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura
M Furlan
Expert Review of Cardiovascular Therapy 2003
Current concepts in the diagnosis and management of thrombotic thrombocytopenic purpura
C Nabhan, HC Kwaan
Hematology/Oncology Clinics of North America 2003
Hemoglobin binds melanoma cell tissue factor and enhances its procoagulant activity
FA Siddiqui, JL Francis
Blood Coagulation & Fibrinolysis 2002
Thrombocytopenic purpura and cardiomyopathy in pregnancy reversed by combined plasma exchange and infusion
EM Cosmai, L Puzis, HM Tsai, EC Lian
European Journal of Haematology 2002
Platelet-Agglutinating Protein p37 from a Patient with Thrombotic Thrombocytopenic Purpura Has Characteristics Similar to Prethrombin 2
SH Kim, SJ Park, JW Lee, JY Jin
Journal of Biochemistry and molecular biology 2002
Aetiology and pathogenesis of thrombotic thrombocytopenic purpura and haemolytic uraemic syndrome: the role of von Willebrand factor-cleaving protease
M Furlan, B Lämmle
Best Practice & Research Clinical Haematology 2001
Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpura
GG Levy, WC Nichols, EC Lian, T Foroud, JN McClintick, BM McGee, AY Yang, DR Siemieniak, KR Stark, R Gruppo, R Sarode, SB Shurin, V Chandrasekaran, SP Stabler, H Sabio, EE Bouhassira, JD Upshaw, D Ginsburg, HM Tsai
Nature 2001
Purification and Properties of Human Melanoma Cell Tissue Factor
FA Siddiqui, A Amirkhosravi, M Amaya, H Desai, T Meyer, JL Francis
Clinical and Applied Thrombosis/Hemostasis 2001
Cocaine-induced acute renal failure, hemolysis, and thrombocytopenia mimicking thrombotic thrombocytopenic purpura
J Volcy, CM Nzerue, A Oderinde, K Hewan-Iowe
American Journal of Kidney Diseases 2000
Plasma from a Patient with Thrombotic Thrombocytopenic Purpura Induces Endothelial Cell Apoptosis and Platelet Aggregation
XW Wu, QZ Li, EC Lian
Thrombosis Research 1999
Current Clinical Practice: Current Management of Thrombotic Thrombocytopenic Purpura
JJ Hong, HC Kwaan
Hematology 1999
Yearbook of Intensive Care and Emergency Medicine 1999
JL Vincent
1999
Thrombotic Thrombocytopenic Purpura: Understanding a Disease No Longer Rare
JL Moake, TW Chow
The American Journal of the Medical Sciences 1998
ANTIBODIES TO VON WILLEBRAND FACTOR–CLEAVING PROTEASE IN ACUTE THROMBOTIC THROMBOCYTOPENIC PURPURA
HM Tsai, EC Lian
The New England journal of medicine 1998
Increased Plasma Soluble-adhesion Molecules in Thrombotic Thrombocytopenic Purpura and Disseminated Intravascular Coagulation
M Shimura, H Wada, K Hiyoyama, T Nakasaki, M Takagi, A Deguchi, Y Mori, M Nisikawa, K Deguchi, H Shiku
Clinical and Applied Thrombosis/Hemostasis 1998
Indications for Emergency Apheresis Procedures
LJ McCarthy, CF Danielson, SS Rothenberger, AA Pineda
Critical Reviews in Clinical Laboratory Sciences 1997
Suki and Massry’s THERAPY OF RENAL DISEASES AND RELATED DISORDERS
WN Suki, SG Massry
1997
Applications of Therapeutic Apheresis in Patients with Malignant Disease
AA Pineda, EC Vamvakas
The oncologist 1997
The pathophysiology and management of thrombotic thrombocytopenic purpura
P Ruggenenti, G Remuzzi
European Journal of Haematology 1996
Increased platelet retention in familial recurrent thrombotic thrombocytopenic purpura
D Karpman, L Holmberg, L Jirgård, S Lethagen
Kidney International 1996
Acute Renal Failure
R Thadhani, M Pascual, JV Bonventre
New England Journal of Medicine 1996
Haemolytic-uraemic syndrome: basic science
JL Moake
The Lancet 1994
Anti-CD36 antibodies in thrombotic thrombocytopenic purpura
NN Tandon, G Rock, GA Jamieson
British Journal of Haematology 1994
Vascular Endothelium
MA Gimbrone, MI Cybulsky, N Kume, T Collins, N Resnick
Annals of the New York Academy of Sciences 1994
Increased serum levels of transforming growth factor β-1 in patients affected by thrombotic thrombocytopenic purpura (TTP): its implications on bone marrow haematopoiesis
G Zauli, L Gugliotta, L Catani, N Vianelli, P Borgatti, MM Belmonte, S Tura
British Journal of Haematology 1993
Mechanism of platelet aggregation induced by a monoclonal antibody requiring Fc portion
AX Yu, XW Wu, JZ Li, EC Lian
Thrombosis Research 1993
Haemolytic—Uraemic Syndrome and Thrombotic Thrombocytopenic Purpura
P Ruggenenti, G Remuzzi
1993
Plasma cytokine levels in thrombotic thrombocytopenic purpura
H Wada, T Kaneko, M Ohiwa, M Tanigawa, S Tamaki, N Minami, H Takahashi, K Deguchi, T Nakano, S Shirakawa
American Journal of Hematology 1992
Thrombotic thrombocytopenic purpura: Clinical results of a French controlled trial
P Henon
Transfusion Science 1992
von Willebrand factor (vWF) abnormalities in thrombotic thrombocytopenic purpura (TTP) and the hemolytic uremic syndrome (HUS)
JL Moake
Transfusion Science 1992
Chronic relapsing thrombotic thrombocytopenic purpura in infants with large von Willebrand factor multimers during remission
MM Chintagumpala, RL Hurwitz, JL Moake, DH Mahoney, CP Steuber
The Journal of Pediatrics 1992
Collateral therapy of thrombotic thrombocytopenic purpura with emphasis on high doses of gamma globulin
A Canevari, D Inverardi
Transfusion Science 1992
Treatment of HUS/TTP
DC Brennan, DL Sommerfeld, JA Gordon
American Journal of Kidney Diseases 1992
Diagnostische Hämatologie
H Huber, H Löffler, D Pastner
1992
Thrombotic microangiopathies
P Ruggenenti, G Remuzzi
Critical Reviews in Oncology/Hematology 1991
Circulating thrombomodulin in thrombotic thrombocytopenic purpura
H Takahashi, M Hanano, K Wada, W Tatewaki, H Niwano, A Shibata, J Tsubouchi, M Nakano, T Nakamura
American Journal of Hematology 1991
A cathepsin-like cysteine proteinase proaggregating activity in thrombotic thrombocytopenic purpura
A Falanga, R Consonni, P Ruggenenti, T Barbui
British Journal of Haematology 1991
Von Willebrand Factor in Thrombotic Thrombocytopenic Purpura and the Hemolytic-Uremic Syndrome
JL Moake, PD McPherson
Transfusion Medicine Reviews 1990
Investigation of plasma von Willebrand factor and circulating platelet aggregating activity in mitomycin C-related hemolytic-uremic syndrome
J Monteagudo, A Pereira, S Roig, JC Reverter, A Ordinas, R Castillo
American Journal of Hematology 1990
Thrombotic thrombocytopenic purpura in two patients with systemic lupus erythematosus: Clinical significance of anti-platelet antibodies
Y Itoh, H Sekine, O Hosono, T Takeuchi, J Koide, M Takano, T Abe
Clinical Immunology and Immunopathology 1990
Thrombotic Thrombocytopenic Purpura and Related Disorders
P Ruggenenti, G Remuzzi
Hematology/Oncology Clinics of North America 1990
Fibrinogen, Thrombosis, Coagulation, and Fibrinolysis
CY Liu, S Chien
1990
Coagulation studies in thrombotic thrombocytopenic purpura, with special reference to von willebrand factor and protein S
H Takahashi, W Tatewaki, T Nakamura, M Hanano, K Wada, A Shibata
American Journal of Hematology 1989
Thrombin generation in patients with thrombotic thrombocytopenic purpura
H Takahashi, W Tatewaki, K Wada, A Shibata
American Journal of Hematology 1989
Electron microscopic study of platelet agglutination induced by thrombotic thrombocytopenic purpura plasma containing 37-KDa platelet agglutinating protein
JZ Li, JW Liu, G Benito, FA Siddiqui, EC Lian
Thrombosis Research 1989
Thrombotic Thrombocytopenic Purpura: Successful Treatment Unlocks Etiologic Secrets
JL Schmidt
Mayo Clinic Proceedings 1989
Abnormal platelet von willebrand factor interaction in patients with TTP
G Rock, P Tittley, JR Taylor
American Journal of Hematology 1988
Permanent neurological complications in patients with thrombotic thrombocytopenic purpura
D Ben-Yehuda, M Rose, Y Michaeli, A Eldor
American Journal of Hematology 1988
Contemporary Internal Medicine
J Bowen, EL Mazzaferri
1988
Platelet-Vessel Wall Interactions
RM Pittilo, SJ Machin
1988
HUS and TTP: Variable expression of a single entity
G Remuzzi, S Garella
Kidney International 1987
Acute Thrombocytopenia and Thrombosis
JG Kelton, WG Murphy
Annals of the New York Academy of Sciences 1987
High incidence of relapses in thrombotic thrombocytopenic purpura
M Rose, A Eldor
The American Journal of Medicine 1987
Absence of plasma prostacyclin stimulating activity deficiency in hemolytic uremic syndrome
N Schlegel, J Maclouf, C Loirat, L Drouet, R Marotte, PY Scarabin, H Mathieu
The Journal of Pediatrics 1987
Plasmapheresis: Development and Application in Treatment of Renal Disorders
JE Balow
Artificial Organs 1986

← Previous 1 2 3 Next →

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts